Skip to content
TrialScanner

NCT02640820

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)

Phase 2Unknown statusPHIOLead

Registry record

Lead sponsor
RXi Pharmaceuticals, Corp.
Conditions
Common Warts; HPV (Human Papillomavirus); Periungual Warts; Plantar Warts
Primary completion
Jan 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02640820 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02640820: Evaluate the Effectiveness... | TrialScanner